WD-40 stock slides as forecast overshadows earnings beat
WD-40 Co. (WDFC) shares fell in the extended session Thursday after the maintenance and cleaning products company topped Wall Street estimates for the quarter but its earnings forecast for the year didn't. WD-40 shares dropped as much as 4% after hours, closing the regular session virtually flat at $178.61. The company reported fiscal second-quarter net income of $16.5 million, or $1.21 a share, compared with $19.5 million, or $1.41 a share, in the year-ago period. Revenue rose to $130.2 million from $130 million in the year-ago period. Analysts surveyed by FactSet had forecast $1.15 a share on revenue of $125.8 million. "While sales volumes in the second quarter were lighter than we anticipated, we continue to believe that most of our growth this fiscal year will be weighted toward the second half of the year," said Steve Brass, WD-40 chief executive, in a statement. The company forecast full-year earnings of $4.80 to $5 a share on revenue of $535 million to $560 million. Analysts, on the other hand, expect full-year earnings of $5.19 a share on revenue of $545.5 million.
-Wallace Witkowski
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-06-23 1630ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits